MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia

Several postmortem studies have reported lower levels of immunoreactivity (IR) for microtubule-associated protein 2 (MAP2) in several cortical regions of individuals with schizophrenia (SZ). However, whether this effect is conserved across multiple brain areas within an individual with SZ or if it i...

Descripción completa

Detalles Bibliográficos
Autores principales: DeGiosio, Rebecca, Kelly, Ryan M., DeDionisio, Adam M., Newman, Jason T., Fish, Kenneth N., Sampson, Allan R., Lewis, David A., Sweet, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713711/
https://www.ncbi.nlm.nih.gov/pubmed/31462659
http://dx.doi.org/10.1038/s41537-019-0081-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713711/
https://www.ncbi.nlm.nih.gov/pubmed/31462659
http://dx.doi.org/10.1038/s41537-019-0081-0

Ejemplares similares